Increasing glycopolymer-based drug delivery success

Oct 19, 2012
Increasing glycopolymer-based drug delivery success
Credit: Thinkstock

Glycopolymer technology is opening up a myriad of new opportunities for disease therapy. European research is investigating novel production strategies for polymers to bring about more efficient targeted drug delivery.

Carbohydrates have been hailed as vital molecules in the human body. They are responsible for biological communication events involved in cellular recognition, inflammation and pathogen infection.

In the treatment of diseases, chemotherapy for example is normally not site-specific. To improve the location-finding ability of drugs to avoid unnecessary damage during therapy, (carbohydrates and peptides) for the recognition of could be a promising research avenue. Moreover, many studies have shown that lectins on cell-cell surfaces mediate interactions and result in better .

The ' conjugation of peptides/salmon calcitonin for increased efficacy' (Wbawba) project focused on the production of and characterisation of A-functional comb polymers by living radical polymerisation techniques. A second strand of the research involved synthesis of sugar-carrying polymers (glycopolymers) and their lectin-binding properties were then investigated.

Wbawba scientists developed a new rapid online polymerisation monitoring technique. In parallel, they used a rapid gel permeation chromatography (GPC) technique to follow copper (Cu)0-mediated polymerisation by monitoring molecular weight.

Optimisation of the conjugation of the and a peptide was achieved by a base-catalysed thiol-ene click reaction. Click chemistry joins together small units very rapidly and generates polymers extremely quickly. The optimum catalysts, reaction time and other required conditions were determined by this systematic structure-property relationship study.

The Wbawba project has also tested a small library of glycopolymers for their specific lectin recognition properties. These polymers show great promise for disease therapy and significantly inhibit the binding of dendritic cell lectins to the human immunodeficiency virus (HIV) isolated glycoprotein gp120, a step in the virus entry into the cell.

Future research planned by the Wbawba during and further to the life of the project will involve investigation of alternative synthesis techniques of glycopolymers that show improved binding to specific lectins.

Work of the Wbawba project has so far provided a basis for the development of glycopolymer-based disease therapies. Based on molecular recognition at the , the scientists have designed and efficiently produced glycopolymers that will target diseased cells specifically.

Explore further: Researchers develop novel method for making electrical cellulose fibers

add to favorites email to friend print save as pdf

Related Stories

Nanotube Coating Meshes with Living Cells

Aug 14, 2006

Using a polymer coating that mimics part of a cell’s outer membrane, a team of investigators at the University of California, Berkeley, have developed a versatile method for targeting carbon nanotubes to specific types ...

Clicking synthetic and biological molecules together

Feb 19, 2008

Dutch researcher Joost Opsteen has developed a method to click polymers together in a controlled manner. Using this method, he can even attach proteins to nanoballs. For instance, this approach could be used to transport ...

Recommended for you

The origins of handedness in life

18 hours ago

Handedness is a complicated business. To simply say life is left-handed doesn't even begin to capture the blooming hierarchy of binary refinements it continues to evolve. Over the years there have been numerous ...

Have our bodies held the key to new antibiotics all along?

21 hours ago

As the threat of antibiotic resistance grows, scientists are turning to the human body and the trillion or so bacteria that have colonized us—collectively called our microbiota—for new clues to fighting microbial infections. ...

Characterizing an important reactive intermediate

Oct 01, 2014

An international group of researchers led by Dr. Warren E. Piers (University of Calgary) and Dr. Heikki M. Tuononen (University of Jyväskylä) has been able to isolate and characterize an important chemical ...

User comments : 0